AGA clinical practice guideline on the prevention and treatment of hepatitis B virus reactivation in at-risk individuals
Gastroenterology; 168 (2), 2025
Hepatitis B reactivation (HBVr) can occur due to a variety of immune-modulating exposures, including multiple drug classes and disease states. Antiviral prophylaxis can be effective in mitigating the risk of HBVr. In select cases, clinical monitoring without antiviral prophylaxis is sufficient for managi...